type here...

CATEGORIES

Pharmaceutics

LATEST

123...11Page 1 of 11

TRENDING

EDITORS CHOICE

Tech Marches On, While Humanity Drags Its Feet

John Nosta -
I thought it would be fun to look back at some of my predictions for health tech from almost a decade ago in Forbes....

Opdivo® Approved for the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Medika Life -
FDA Approved Opdivo demonstrated superior overall survival benefit compared to docetaxel or paclitaxel in ESCC Patients

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

FDA approves Ready-to-Use Ephedrine Injection, Emerphed™

Medika Life -
Nexus Pharmaceuticals, Inc. Announces Approval of Emerphed™ (ephedrine sulfate) Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial)

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories